ElectRx receives FDA warning on imports of prescription drugs from Canada

ElectRx has been issued a warning from the Food and Drug Administration after the agency found it allegedly distributed unauthorized, misbranded drugs, Becker’s Hospital Review reports. ElectRx coordinates the dispensing of the prescription drugs by Canadian pharmacies to enrollees of certain employee-sponsored health insurance plans. The company issued a statement ensuring customers it is working with the FDA but maintains that the safety of the drugs is not an issue.